Suven Life Science Target achieved -Upgrading Target
- Suven Life Science recommended on Aug 2014 with target of 240 has been achieved in just 3 months.
- We feel this is still very good company and more upside is left.This is just a start of great stock in patent business,a unique company in India .
- We are upgrading the Target to 440 Rs with 2 yrs time frame
Old Recommendation --> http://niftyhistoricaldata.blogspot.com/2014/08/suven-life-sciences-multi-bagger-240-1.html
Dear Sir,
ReplyDeletePlease analyse Suven Q2 results. It seems poor. Kindly share your views.
Bhavin,
ReplyDeleteYes,PAT has dropped by 45 % .Company says,i ts because of absence of pre-launch supplies of intermediates for 3 of the NCE’s which were done last year.The repeat order for these supplies may happen after a gap of 12-18 months.I belive its common for the research companies where 1 quarter is up and 1 quarter its down. So hold with 2 yrs timeframe